Company intelligence / Profile preview

Smartweed

Ownership: Private
Development stage: Other

Overview

Smartweed is a biotechnology company focused on the development of therapeutic compounds derived from the Persicaria (Smartweed) genus of plants. The company leverages traditional ethnobotanical knowledge combined with modern pharmacological screening to identify bioactive molecules for applications in pain management, inflammation, and dermatology. Their research primarily centers on the anti-inflammatory and antimicrobial properties of polygodial and other sesquiterpene dialdehydes found in the plant. Smartweed aims to bridge the gap between natural product discovery and standardized pharmaceutical applications.

Therapeutic areas: ImmunologyNeurologyDermatology
Modalities: Small moleculeNatural product
Industry: Biotech

Beyond the preview

Go deeper on Smartweed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smartweed.

Explore the full profile